| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.07 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.07 |